Communiqués Evotec SE

Actions

EVT

DE0005664809

Marché Fermé - Xetra Autres places de cotation 17:35:04 31/05/2024			Varia. 5j.	Varia. 1 janv.
8,655 ^EUR	+3,04 %		-2,15 %	-59,33 %

30/05	Evotec s'associe à des institutions et à une entreprise françaises pour mener des recherches sur l'obésité	MT
30/05	Evotec s'associe à une collaboration visant à identifier de nouvelles thérapies pour l'obésité et les maladies métaboliques	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	30/05	EQ
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases	30/05	EQ
Evotec : Update of the Declaration of Conformity with the German Corporate Governance Code for the Year 2023 (May 2024) 127.622 KB	29/05	PU
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington's disease	29/05	AQ
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease	28/05	EQ
Evotec : today announced receipt of a written notice from NASDAQ	27/05	PU
Evotec : Additional Information regarding agenda item 5 (Approval of Remuneration Report)	27/05	PU
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	27/05	EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	27/05	EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	24/05	EQ
Evotec : Letter of the Chair of Supervisory Board to the Shareholders of Evotec	22/05	PU
Evotec : Interim STATEMENT 3M 2024 - Form 6-K	22/05	PU
Evotec reports Q1 2024 results and provides corporate update	22/05	EQ
Evotec : Company Presentation 6.135 MB	21/05	PU
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	21/05	EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	16/05	EQ
Evotec SE to announce results for first quarter 2024 on 22 may 2024	15/05	EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	14/05	EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	14/05	EQ
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	13/05	EQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Evotec SE

Actions

EVT

DE0005664809

Communiqués

Filtres